Urotensin II upregulates migration and cytokine gene expression in leukocytes of the African clawed frog, Xenopus laevis

General and Comparative Endocrinology

Volumn 216, Issue , 2015, Pages 46-53

  Tomiyama, Shiori ^a   Nakamachi, Tomoya ^a   Uchiyama, Minoru ^a   Matsuda, Kouhei ^a   Konno, Norifumi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Cytokine; Leukocyte; Migration; Urotensin II (UII); Urotensin II receptor (UTR); Xenopus laevis

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CYTOKINE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; URANTIDE; UROTENSIN II; UROTENSIN RECEPTOR; UROTENSIN;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CELL MIGRATION ASSAY; CONTROLLED STUDY; EF1ALPHA; ENZYME INHIBITION; G CSF GENE; GENE; GENE EXPRESSION; IL BETA GENE; IMMUNE SYSTEM; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; MALE; MIF GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TGF BETA1 GENE; TNF ALPHA GENE; UPREGULATION; XENOPUS LAEVIS; ANIMAL; CELL CULTURE; CELL MOTION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; LEUKOCYTE; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; GENE EXPRESSION REGULATION; INTERLEUKIN-1BETA; LEUKOCYTES; LIPOPOLYSACCHARIDES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA; UROTENSINS; XENOPUS LAEVIS;

EID: 84930177324     PISSN: 00166480     EISSN: 10956840     Source Type: Journal    
DOI: 10.1016/j.ygcen.2015.04.009     Document Type: Article

References (50)

1. Aiyar N., Johns D.G., Ao Z., Disa J., Behm D.J., Foley J.J., Buckley P.T., Sarau H.M., van-der-Keyl H.K., Elshourbagy N.A., Douglas S.A. Cloning and pharmacological characterization of the cat urotensin-II receptor (UT). Biochem. Pharmacol. 2005, 69:1069-1079.
2. Aizawa Y., Nogawa N., Kosaka N., Maeda Y., Watanabe T., Miyazaki H., Kato T. Expression of erythropoietin receptor-like molecule in Xenopus laevis and erythrocytopenia upon administration of its recombinant soluble form. J. Biochem. 2005, 138:167-175.
3. Ames R.S., Sarau H.M., Chambers J.K., Willette R.N., Aiyar N.V., Romanic A.M., Louden C.S., Foley J.J., Sauermelch C.F., et al. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 1999, 401:282-286.
4. Balment R.J., Song W., Ashton N. Urotensin II: ancient hormone with new functions in vertebrate body fluid regulation. Ann. N. Y. Acad. Sci. 2005, 1040:66-73.
5. Barrette P.O., Schwertani A.G. A closer look at the role of urotensin II in the metabolic syndrome. Front. Endocrinol. 2012, 3:165.
6. Bousette N., Patel L., Douglas S.A., Ohlstein E.H., Giaid A. Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta. Atherosclerosis 2004, 176:117-123.
7. Chadzinska M., Plytycz B. Differential migratory properties of mouse, fish, and frog leukocytes treated with agonists of opioid receptors. Dev. Comp. Immunol. 2004, 28:949-958.
8. Chai S.B., Li X.M., Pang Y.Z., Qi Y.F., Tang C.S. Increased plasma levels of endothelin-1 and urotensin-II in patients with coronary heart disease. Heart Vessels 2010, 25:138-143.
9. Conlon J.M., O'Harte F., Smith D.D., Tonon M.C., Vaudry H. Isolation and primary structure of urotensin II from the brain of a tetrapod, the frog Rana ridibunda. Biochem. Biophys. Res. Commun. 1992, 188:578-583.
10. Coulouarn Y., Jégou S., Tostivint H., Vaudry H., Lihrmann I. Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. FEBS Lett. 1999, 457:28-32.
11. Coulouarn Y., Lihrmann I., Jegou S., Anouar Y., Tostivint H., Beauvillain J.C., Conlon J.M., Bern H.A., Vaudry H. Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:15803-15808.
12. Cui X., Han Y., Pan Y., Xu X., Ren W., Zhang S. Molecular cloning, expression and functional analysis of interleukin-8 (IL-8) in South African clawed frog (Xenopus laevis). Dev. Comp. Immunol. 2011, 35:1159-1165.
13. Dai H.Y., He T., Li X.L., Xu W.L., Ge Z.M. Urotensin-2 promotes collagen synthesis via ERK1/2-dependent and ERK1/2-independent TGF-β1 in neonatal cardiac fibroblasts. Cell Biol. Int. 2011, 35:93-98.
14. Dai H.Y., Kang W.Q., Wang X., Yu X.J., Li Z.H., Tang M.X., Xu D.L., Li C.W., Zhang Y., Ge Z.M. The involvement of transforming growth factor-beta1 secretion in urotensin II-induced collagen synthesis in neonatal cardiac fibroblasts. Regul. Pept. 2007, 140:88-93.
15. Do-Rego J.C., Chatenet D., Orta M.H., Naudin B., Le Cudennec C., Leprince J., Scalbert E., Vaudry H., Costentin J. Behavioral effects of urotensin-II centrally administered in mice. Psychopharmacology 2005, 183:103-117.
16. Douglas S.A., Ohlstein E.H. Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease. Trends Cardiovasc. Med. 2000, 10:229-237.
17. Etienne-Manneville S., Hall A. Rho GTPases in cell biology. Nature 2002, 420:629-635.
18. Evans D.H., Hyndman K.A., Cornwell E., Buchanan P. Urotensin II and its receptor in the killifish gill: regulators of NaCl extrusion. J. Exp. Biol. 2011, 214:3985-3991.
19. Gruson D., Rousseau M.F., Ketelslegers J.M., Hermans M.P. Raised plasma urotensin II in type 2 diabetes patients is associated with the metabolic syndrome phenotype. J. Clin. Hypertens. 2010, 12:653-660.
20. Hadji-Azimi I., Coosemans V., Canicatti C. Atlas of adult Xenopus laevis laevis hematology. Dev. Comp. Immunol. 1987, 11:807-874.
21. Hassan G.S., Douglas S.A., Ohlstein E.H., Giaid A. Expression of urotensin-II in human coronary atherosclerosis. Peptides 2005, 26:2464-2472.
22. Ishii A., Kawasaki M., Matsumoto M., Tochinai S., Seya T. Phylogenetic and expression analysis of amphibian Xenopus Toll-like receptors. Immunogenetics 2007, 59:281-293.
23. Konno N., Fujii Y., Imae H., Kaiya H., Mukuda T., Miyazato M., Matsuda K., Uchiyama M. Urotensin II receptor (UTR) exists in hyaline chondrocytes: a study of peripheral distribution of UTR in the African clawed frog, Xenopus laevis. Gen. Comp. Endocrinol. 2013, 85:44-56.
24. Lee C.Y., Tsai Y.T., Loh S.H., Liu J.C., Chen T.H., Chao H.H., Cheng T.H., Chen J.J. Urotensin II induces interleukin 8 expression in human umbilical vein endothelial cells. PLoS ONE 2014, 9:e90278.
25. Liang D.Y., Liu L.M., Ye C.G., Zhao L., Yu F.P., Gao D.Y., Wang Y.Y., Yang Z.W., Wang Y.Y. Inhibition of UII/UTR system relieves acute inflammation of liver through preventing activation of NF-κB pathway in ALF mice. PLoS ONE 2013, 8:e64895.
26. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
27. Lu W., Greenwood M., Dow L., Yuill J., Worthington J., Brierley M.J., McCrohan C.R., Riccardi D., Balment R.J. Molecular characterization and expression of urotensin II and its receptor in the flounder (Platichthys flesus): a hormone system supporting body fluid homeostasis in euryhaline fish. Endocrinology 2006, 147:3692-3708.
28. Maguire J.J., Kuc R.E., Wiley K.E., Kleinz M.J., Davenport A.P. Cellular distribution of immunoreactive urotensin-II in human tissues with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries. Peptides 2004, 25:1767-1774.
29. Marchese A., Heiber M., Nguyen T., Heng H.H., Saldivia V.R., Cheng R., Murphy P.M., Tsui L.C., Shi X., Gregor P., et al. Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors. Genomics 1995, 29:335-344.
30. Morales H., Muharemagic A., Gantress J., Cohen N., Robert J. Bacterial stimulation upregulates the surface expression of the stress protein gp96 on B cells in the frog Xenopus. Cell Stress Chaperones 2003, 8:265-271.
31. Mori A., Satsu H., Shimizu M. New model for studying the migration of immune cells into intestinal epithelial cell monolayers. Cytotechnology 2003, 43:57-64.
32. Nagata S., Nishiyama S., Ikazaki Y. Bacterial lipopolysaccharides stimulate production of XCL1, a calcium-dependent lipopolysaccharide-binding serum lectin, in Xenopus laevis. Dev. Comp. Immunol. 2013, 40:94-102.
33. Nikolaeva S., Bachteeva V., Fock E., Herterich S., Lavrova E., Borodkina A., Gambaryan S., Parnova R. Frog urinary bladder epithelial cells express TLR4 and respond to bacterial LPS by increase of iNOS expression and l-arginine uptake. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012, 303:R1042-R1052.
34. Nobata S., Donald J.A., Balment R.J., Takei Y. Potent cardiovascular effects of homologous urotensin II (UII)-related peptide and UII in unanesthetized eels after peripheral and central injections. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 300:R437-R446.
35. Pearson D., Shively J.E., Clark B.R., Geschwind I.I., Barkley M., Nishioka R.S., Bern H.A. Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. Proc. Natl. Acad. Sci. U.S.A. 1980, 77:5021-5024.
36. Robert J., Ohta Y. Comparative and developmental study of the immune system in Xenopus. Dev. Dyn. 2009, 238:1249-1270.
37. Rodrigo R., González J., Paoletto F. The role of oxidative stress in the pathophysiology of hypertension. Hypertens. Res. 2011, 34:431-440.
38. Romanelli R.G., Laffi G., Vizzutti F., Del Bene R., Marra F., Caini P., Guerra C.T., La Villa G., Barletta G. Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis. Dig. Liver Dis. 2011, 43:314-318.
39. Segain J.P., Rolli-Derkinderen M., Gervois N., Raingeard de la Blétière D., Loirand G., Pacaud P. Urotensin II is a new chemotactic factor for UT receptor-expressing monocytes. J. Immunol. 2007, 179:901-909.
40. Singh R., Rai U. Immunomodulatory role of urotensins in teleost Channa punctatus. Gen. Comp. Endocrinol. 2011, 170:613-621.
41. Song W., Abdel-Razik A.E., Lu W., Ao Z., Johns D.G., Douglas S.A., Balment R.J., Ashton N. Urotensin II and renal function in the rat. Kidney Int. 2006, 69:1360-1368.
42. Sugo T., Murakami Y., Shimomura Y., Harada M., Abe M., Ishibashi Y., Kitada C., Miyajima N., Suzuki N., Mori M., Fujino M. Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain. Biochem. Biophys. Res. Commun. 2003, 310:860-868.
43. Tian L., Li C., Qi J., Fu P., Yu X., Li X., Cai L. Diabetes-induced upregulation of urotensin II and its receptor plays an important role in TGF-beta1-mediated renal fibrosis and dysfunction. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E1234-E1242.
44. Tostivint H., Joly L., Lihrmann I., Parmentier C., Lebon A., Morisson M., Calas A., Ekker M., Vaudry H. Comparative genomics provides evidence for close evolutionary relationships between the urotensin II and somatostatin gene families. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:2237-2242.
45. Vicente-Manzanares M., Cabrero J.R., Rey M., Pérez-Martínez M., Ursa A., Itoh K., Sánchez-Madrid F. A role for the Rho-p160 Rho coiled-coil kinase axis in the chemokine stromal cell-derived factor-1alpha-induced lymphocyte actomyosin and microtubular organization and chemotaxis. J. Immunol. 2002, 168:400-410.
46. Watanabe T., Suguro T., Kanome T., Sakamoto Y., Kodate S., Hagiwara T., Hongo S., Hirano T., Adachi M., Miyazaki A. Human urotensin II accelerates foam cell formation in human monocyte-derived macrophages. Hypertension 2005, 46:738-744.
47. Xu S., Jiang H., Wu B., Yang J., Chen S. Urotensin II induces migration of endothelial progenitor cells via activation of the RhoA/Rho kinase pathway. Tohoku J. Exp. Med. 2009, 219:283-288.
48. Yano K., Hicks J.W., Vaudry H., Conlon J.M. Cardiovascular actions of frog urotensin II in the frog, Rana catesbeiana. Gen. Comp. Endocrinol. 1995, 97:103-110.
49. Yano K., Vaudry H., Conlon J.M. Spasmogenic actions of frog urotensin II on the bladder and ileum of the frog, Rana catesbeiana. Gen. Comp. Endocrinol. 1994, 96:412-419.
50. Zhou C.H., Wan Y.Y., Chu X.H., Song Z., Xing S.H., Wu Y.Q., Yin X.X. Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-κB pathway in tumor-bearing nude mice. Oncol. Lett. 2012, 4:1259-1263.